Topic
heart failure
AstraZeneca launches K+ Connect to advance hyperkalemia management in heart failure and chronic kidney disease
AstraZeneca Pharma India Ltd., has launched K+ Connect, a pan-India multidisciplinary initiative focused on advancing the management of hyperkalemia in patients with heart failure…
Abbott introduces TriClip™ in India
Abbott has launched the TriClip™ transcatheter edge-to-edge repair (TEER) system in India. This device is specifically designed to treat tricuspid…
Kauvery Heart Institute Introduces Specialised Cardiac Programmes
Kauvery Heart Institute at Kauvery Hospital has launched Complex High-Risk Indicated Procedures (CHIP), a set of specialised cardiac programmes aimed…
Cadila Pharma Launches New Triple‑Action Therapy for Better BP Control
Cadila Pharmaceuticals has launched Ciledge Trio, a fixed‑dose combination therapy designed to deliver sustained blood pressure (BP) control with improved tolerability…
Bayer Expands Indication of Kerendia™ (Finerenone) in India to Address Heart Failure with Preserved and Mildly Reduced Ejection Fraction
Bayer announced a major expansion of its innovative therapy, Kerendia™ (finerenone), in India, now approved for the treatment of adult…
EASO algorithm recommends semaglutide for obesity mgmt in patients with cardiovascular disease, diabetes, heart failure
Guidelines state that obesity management must be long-term, multi-component, and personalised The European Association for the Study of Obesity (EASO)…
USV launches combination drug Xenia for diabetes care in India
Empagliflozin and its combinations are now available at one-fifth the cost, enhancing affordability Healthcare company USV has launched Xenia (Empagliflozin and its combinations),…